Stellar Reports Positive Research Results from KLH Glycosylation Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Stellar Biotechnologies (SBOT) Gains 45% Following Positive Study Results
June 21, 2018 8:06 AM EDTStellar Biotechnologies (NASDAQ: SBOT) gains 45% in pre-open trade after the company announced the successful completion of a research study focused on the molecular composition of the company's KLH products. The quality analysis was completed as part of Stellar's initiatives to support later stage clinical trials of... More
